DSGN FY 2022 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$466,000

Operating Income

-$68M

Net Income

-$63M

EPS (Diluted)

$-1.14

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$52M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$341M

Total Liabilities

$14M

Stockholders' Equity

$327M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$466,000	$0	—
Operating Income	-$68M	-$36M	-88.6%
Net Income	-$63M	-$36M	-78.2%